A

Addex Therapeutics Ltd
D

ADXN

8.39000
USD
0.52
(6.61%)
Market Open
Volume
3,481
EPS
0
Div Yield
-
P/E
-0
Market Cap
8,966,670
OverviewSignalsIdeasNews
Related Instruments
    EOSUSD
    EOSUSD
    0.06588
    (10.96%)
    0.77639 USD
    A
    ATOM
    -0.15000
    (-2.53%)
    5.78000 USD
    E
    EOS
    -0.220
    (-0.96%)
    22.720 USD
    L
    LINK
    0.08000
    (1.61%)
    5.06000 USD
    T
    TRX
    -0.00600
    (-1.62%)
    0.36500 USD
    V
    VET
    -0.05500
    (-0.55%)
    9.90500 USD
    More
News

Title: Addex Therapeutics Ltd

Sector: Healthcare
Industry: Biotechnology
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.